-
Cardiovascular Effects of Semaglutide in Patients With Obesity, With or Without Type 2 Diabetes (T2DM): An Umbrella Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Fixed-Dose Combination Rosuvastatin and Ezetimibe vs. Simvastatin Plus Ezetimibe for the Treatment of Hypercholesterolemia in Patients at High Risk and Very High Risk of Cardiovascular Disease in Algeria
Sep 9, 2025, 16:22 PM -
Evaluating the Cost-Effectiveness of Nasal Adrenaline Spray vs. Adrenaline Autoinjector for Treatment of Anaphylaxis: A Cost-Utility Modeling Approach
Sep 9, 2025, 16:22 PM -
EQ-5D Utility Trends in NMOSD: Impact of Time and Disability
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of the 13-Valent Pneumococcal Conjugate Vaccine Compared With Higher-Valent Alternatives in the Pediatric Population of Paraguay
Sep 9, 2025, 16:22 PM -
Comparing HTA Outcomes and Rationale for Decision Making Between Countries With Mature vs. Newly Founded HTA Systems: Evidence From England, France, and Greece
Sep 9, 2025, 16:22 PM -
Confirmation of Diagnosis Method for Robust Participant Selection in Direct-to-Patient Real-World Evidence Studies
Sep 9, 2025, 16:22 PM -
Comparative Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole for the Treatment of Invasive Aspergillosis in Algerian Hospital Setting
Sep 9, 2025, 16:22 PM -
The Relationship Between Surrogate Endpoints and Overall Survival in Myelofibrosis Clinical Trials: Results From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Estimation of Utility Weights for Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Previously Treated with a Covalent Bruton Kinase Inhibitor (cBTKi)
Sep 9, 2025, 16:22 PM -
Nutritional Profile and Cost Evaluation of Elderly Patients in Home Care Within the Brazilian Private Health Sector: A Retrospective Study
Sep 9, 2025, 16:22 PM -
The HERC Database of Mapping Studies: A 2025 Update of a Live Systematic Review of Studies Predicting EQ-5D From Other Patient-Reported Outcome Measures
Sep 9, 2025, 16:22 PM -
How Can the Threshold Method Guide the Choice of Treatments? Illustration in French Patients With Hemophilia A or B
Sep 9, 2025, 16:22 PM -
Barriers and Facilitators Influencing the Development of Complex Generics: An Exploratory Study
Sep 9, 2025, 16:22 PM -
Supplementing Single-Arm Trial Data in NICE Submissions: Are Synthetic Approaches Leading the Charge?
Sep 9, 2025, 16:22 PM -
Survival Model Uncertainty in Economic Modeling: Evaluating Bootstrap and Cholesky Decomposition Methods
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Control-IQ Hybrid Closed-Loop System in Adults With Type 1 Diabetes in Sweden
Sep 9, 2025, 16:22 PM -
From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of a Novel Scalp Cooling Device to Alleviate Chemotherapy-Induced Alopecia in Patients With Early Breast Cancer
Sep 9, 2025, 16:22 PM -
Integration of Germany’s AMNOG Framework With the Joint Clinical Assessment Process
Sep 9, 2025, 16:22 PM
